As previously reported, Piper Sandler analyst Jason Bednar initiated coverage of ICU Medical (ICUI) with an Overweight rating and $145 price target The infusion pump market faced regulatory and ...

Medical device company ICU Medical (NASDAQ:ICUI) will be announcing earnings results this Thursday after market close. Here’s ...

In trading on Wednesday, shares of ICU Medical, Inc. (NASD: ICUI) crossed above their 200 day moving average of $66.17, changing hands as high as $66.20 per share.

ICU Medical beat analysts’ revenue expectations by 1% last quarter, reporting revenues of $589.1 million, up 6.5% year on year. It was a mixed quarter for the company, with an impressive beat of ...

ICU Medical now looks to have a multiyear road to get that new business unit up to speed. In the second quarter of 2022, management cut its full-year adjusted EPS and EBITDA guidance range by ...

View ICU Medical, Inc. ICUI stock quote prices, financial information, real-time forecasts, and company news from CNN.

ICU Medical starts off 2022 with the considerable task of integrating Smiths Medical. Operating synergies should provide a path to ICUI trading at 3.35x-3.5x sales in FY'24.

ICU Medical’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $186.40 (compared to the current share price of $134.32).

ICU Medical shares do look undervalued, but valuation of slow-growing small-cap medical device companies is tricky, and I'd prefer to see more evidence of stabilization and reacceleration.

What happenedShares of ICU Medical (NASDAQ: ICUI), a medical device company specializing in intravenous treatment solutions, were on the move today following the announcement of a cash and stock ...

ICU Medical Inc. ICUI 0.55% agreed to buy Pfizer Inc.’s infusion-systems business in a $1 billion cash-and-stock deal, giving the California medical-device maker a larger footprint in the global ...